References
A Collaborative Study of the Group Francais de Cytogenetique Hematologique (1996) Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings outcome. Blood 87(8):3135–3142
Tanguy-Schmidt A, Rousselot P, Chalandon Y, Cayuela JM, Hayette S, Vekemans MC, Escoffre M, Huguet F, Rea D, Delannoy A, Cahn JY, Vernant JP, Ifrah N, Dombret H, Thomas X (2012) Long-term follow-up of the Imatinib GRAAPH-2003 Study in newly diagnosed patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: a GRAALL study. Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation. doi:10.1016/j.bbmt.2012.08.021
Snyder DS (2000) Allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Biol Blood Marrow Transplant: J American Soc Blood Marrow Transplant 6(6):597–603
Caocci G, Vacca A, Ledda A, Murgia F, Piras E, Greco M, Arras M, Atzeni S, Littera R, La Nasa G (2012) Prophylactic and preemptive therapy with dasatinib after hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplantation 18(4):652–654. doi:10.1016/j.bbmt.2011.12.587
Loken MR, Alonzo TA, Pardo L, Gerbing RB, Raimondi SC, Hirsch BA, Ho PA, Franklin J, Cooper TM, Gamis AS, Meshinchi S (2012) Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group. Blood 120(8):1581–1588. doi:10.1182/blood-2012-02-408336
Grigoriou EE, Psarra KK, Garofalaki MK, Tziotziou EC, Papasteriades CA (2012) BCR-ABL fusion protein detection in peripheral blood and bone marrow samples of adult precursor B-cell acute lymphoblastic leukemia patients using the flow cytometric immunobead assay. Clinical Chem Lab Med: CCLM / FESCC 50(9):1657–1663. doi:10.1515/cclm-2011-0686
Nakasone H, Kanda Y, Takasaki H, Nakaseko C, Sakura T, Fujisawa S, Yokota A, Yano S, Usuki K, Maruta A, Abe D, Hoshino T, Takahashi S, Kanamori H, Okamoto S (2010) Prophylactic impact of imatinib administration after allogeneic stem cell transplantation on the incidence and severity of chronic graft versus host disease in patients with Philadelphia chromosome-positive leukemia. Leukemia: J Leukemia Soc Am, Leukemia Research Fund, UK 24(6):1236–1239. doi:10.1038/leu.2010.83
Yoshihara S, Ando T, Ogawa H (2012) Extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: an easily overlooked but significant pattern of relapse. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplantation. doi:10.1016/j.bbmt.2012.05.010
Rytting ME, Wierda WG (2004) Central nervous system relapse in two patients with chronic myelogenous leukemia in myeloid blastic phase on imatinib mesylate therapy. Leukemia Lymphoma 45(8):1623–1626. doi:10.1080/10428190410001667703
Conflict of interest
The authors declare that they have no conflict of interest
Author information
Authors and Affiliations
Corresponding author
Additional information
Chieh-Lin Jerry Teng and Jui-Ting Yu contributed equally to this manuscript.
Rights and permissions
About this article
Cite this article
Teng, CL.J., Yu, JT., Chen, HC. et al. Maintenance therapy with dasatinib after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia. Ann Hematol 92, 1137–1139 (2013). https://doi.org/10.1007/s00277-012-1670-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-012-1670-4